CAR-T platform targeting senescence-associated surface antigens
Deciduous Therapeutics · published 2025-09-28 · filed 2024-06-17
▸ inventors
M. Amor, S. Lowe
▸ abstract
Chimeric antigen receptor T-cells engineered against uPAR and B2M-derived neo-epitopes preferentially expressed on senescent cells in fibrotic and oncologic indications.
▸ topics
▸ source links
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
